BRYAN K KEE to Microsatellite Repeats
This is a "connection" page, showing publications BRYAN K KEE has written about Microsatellite Repeats.
Connection Strength
0.044
-
Phase II study of durvalumab (anti-PD-L1) and trametinib (MEKi) in microsatellite stable (MSS) metastatic colorectal cancer (mCRC). J Immunother Cancer. 2022 08; 10(8).
Score: 0.044